Skip to main content
TipRanks
Go Ultimate75% OFF

Geron (GERN) Drug Pipeline

2,602 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Imetelstat SodiumAcute Myeloid Leukemia, Myelodysplastic SyndromesPhase IIActive Not RecruitingStudy to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based TherapyOct 13, 2022―
Ruxolitinib, Imetelstat Sodium, Pacritinib, Momelotinib, FedratinibMyelofibrosisPhase IRecruitingA Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With MyelofibrosisMay 05, 2022―
Imetelstat, Best Available Therapy (BAT)MyelofibrosisPhase IIIRecruitingA Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor TreatmentSep 18, 2020
Imetelstat SodiumMyelodysplastic Syndromesphase2AndPhase3Active Not RecruitingStudy to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)Oct 27, 2015―
Imetelstat 4.7 Mg/Kg, Imetelstat 9.4 Mg/KgMyelofibrosisPhase IICompletedStudy to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) InhibitorApr 21, 2015―
ImetelstatPrimary Myelofibrosis, Secondary Myelofibrosis, Myeloid MalignanciesPhase IICompletedImetelstat Sodium in Treating Participants With Primary or Secondary MyelofibrosisNov 18, 2012―
Bevacizumab, Paclitaxel, Imetelstat SodiumLocally Recurrent Or Metastatic Breast CancerPhase IICompletedImetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast CancerDec 02, 2010―
Imetelstat (7.5 Mg/Kg), Lenalidomide Standard Of Care, Imetelstat (9.4 Mg/Kg)Multiple MyelomaPhase IICompletedOpen Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple MyelomaNov 16, 2010―
ImetelstatEssential Thrombocythemia, Polycythemia VeraPhase IICompletedOpen Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia VeraNov 11, 2010―
Bevacizumab, ImetelstatNon-small Cell Lung CancerPhase IICompletedImetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)Jun 03, 2010―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Geron Corporation (GERN) have in its pipeline
Geron GERN is currently developing the following drugs: Imetelstat Sodium, Ruxolitinib, Imetelstat Sodium, Pacritinib, Momelotinib, Fedratinib, Imetelstat, Best Available Therapy (BAT), Imetelstat 4.7 Mg/Kg, Imetelstat 9.4 Mg/Kg, Imetelstat, Bevacizumab, Paclitaxel, Imetelstat Sodium, Imetelstat (7.5 Mg/Kg), Lenalidomide Standard Of Care, Imetelstat (9.4 Mg/Kg), Bevacizumab, Imetelstat, Grn163l, Imetelstat Sodium (Grn163l). These drug candidates are in various stages of clinical development as the company works toward FDA approval.